Ambeed.cn

首页 / 抑制剂/激动剂 / 泛素 / 蛋白酶体 / ONX-0914

ONX-0914 {[allProObj[0].p_purity_real_show]}

货号:A354826 同义名: PR-957

ONX-0914 (PR-957) 是一种选择性免疫蛋白酶体的胰凝乳蛋白酶样亚基低分子质量多肽-7 (LMP7) 抑制剂。它通过 p-TEFb 激活介导的 HSF-1 激活阻断细胞因子生产并减少实验性关节炎的进展。ONX-0914 是一种不可逆的非竞争性抑制剂 (Ki = 5.2 μM) 并通过 p-TEFb 激活介导的 HSF-1 激活再活化潜伏的 HIV-1。

ONX-0914 化学结构 CAS号:960374-59-8
ONX-0914 化学结构
CAS号:960374-59-8
ONX-0914 3D分子结构
CAS号:960374-59-8
ONX-0914 化学结构 CAS号:960374-59-8
ONX-0914 3D分子结构 CAS号:960374-59-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

ONX-0914 纯度/质量文件 产品仅供科研

货号:A354826 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell, 2024, 101755. Ambeed. [ A399663 ]
EMBO J., 2024. Ambeed. [ A295334 ]
JMC, 2024, 67(20): 18265-18289. Ambeed. [ A538667 , A341145 , A117430 , A172297 ]
JMC, 2024. Ambeed. [ A210558 , A1518164 ]
Cell Death Discov., 2024, 10, 436. Ambeed. [ A384235 ]
更多 >
产品名称 20S proteasome Proteasome 其他靶点 纯度
Ixazomib ++++

20S proteasome, IC50: 3.4 nM

20S proteasome, Ki: 0.93 nM

99%+
Delanzomib +++

Chymotrypsin-like proteasome, IC50: 3.8 nM

98%
Celastrol +

20S proteasome, IC50: 2.5 μM

98%
MLN9708 +++

20S proteasome, IC50: 3.4 nM

20S proteasome, Ki: 0.93 nM

99%
Bortezomib ++++

20S proteasome, Ki: 0.6 nM

98%
Oprozomib ++

20S proteasome LMP7, IC50: 82 nM

20S proteasome β5, IC50: 36 nM

99%+
Epoxomicin 99%
PI-1840 ++

Chymotrypsin-like proteasome, IC50: 27 nM

98%
VR23 +++

Chymotrypsin-like proteasomes, IC50: 3 μM

Trypsin-like proteasomes, IC50: 1 nM

98%
Carfilzomib ++

Proteasome, IC50: 5 nM

98%
(R)-MG-132 +

Proteasome, IC50: 100 nM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

ONX-0914 生物活性

描述 The immunoproteasome is a class of proteasome predominantly synthesized in monocytes and lymphocytes. ONX-0914 is a selective inhibitor of low-molecular mass polypeptide-7 (LMP7), the chymotrypsin-like subunit of the immunoproteasome. In human peripheral blood mononuclear cells (PBMCs), 100 nM ONX-0914 blocked the activity of LMP7 by 480% with minimal inhibitory effect on LMP2 or MECL-1. ONX-0914 at 200 nM also inhibited the production of inflammatory cytokines, such as IL-23, TNF-α and IL-6, in LPS-stimulated human PBMCs. ONX-0914 at the doses of 25-300 nM inhibited chymotrypsin-like activity of liver proteasomes isolated from WT mice but not Psmb8-/- mice. In BALB/c mice, an intravenous administration of ONX-0914 at 1-10 mg/kg inhibited the activity of LMP7 in both blood and kidney. The intravenous treatment of female C57BL/6 mice with ONX-0914 (6 mg/kg) for 5 days suppressed the infection induced by recombinant vaccinia virus expressing UTY protein. In a mouse model of collagen antibody-induced arthritis, ONX-0914 at 2, 6, or 10 mg/kg delayed disease progression in a concentration-dependent manner and completely ameliorated visible clinical signs at the dose of 10 mg/kg[2].
作用机制 ONX-0914 is a selective inhibitor for the chymotrypsin-like subunit of immunoproteasome, LMP7. It contains a ketoepoxide pharmacophore that covalently modifies the proteasomal active sites of LMP7.

ONX-0914 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
human Raji cells Function assay Inhibition of proteasome subunit beta-5i in human Raji cells using BODIPY-NC005 by fluorescent densitometry, IC50=5.7 nM 25006746
human Raji cells Function assay Inhibition of 20s proteasome subunit beta-5c in human Raji cells using BODIPY-NC005 by fluorescent densitometry, IC50=0.054 μM 25006746
human Raji cells Function assay Inhibition of proteasome subunit beta-1i in human Raji cells using BODIPY- epoxomicin by fluorescent densitometry, IC50=0.46 μM 25006746
human Raji cells Function assay Inhibition of proteasome subunit beta-2i in human Raji cells using BODIPY- epoxomicin by fluorescent densitometry, IC50=0.59 μM 25006746

ONX-0914 参考文献

[1]Muchamuel T, Basler M, Aujay MA, Suzuki E, Kalim KW, Lauer C, Sylvain C, Ring ER, Shields J, Jiang J, Shwonek P, Parlati F, Demo SD, Bennett MK, Kirk CJ, Groettrup M. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med. 2009 Jul;15(7):781-7. doi: 10.1038/nm.1978. Epub 2009 Jun 14. Erratum in: Nat Med. 2009 Nov;15(11):1333. PMID: 19525961.

ONX-0914 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.72mL

0.34mL

0.17mL

8.61mL

1.72mL

0.86mL

17.22mL

3.44mL

1.72mL

ONX-0914 技术信息

CAS号960374-59-8
分子式C31H40N4O7
分子量 580.672
别名 PR-957
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Store in freezer, under -20°C

溶解度

DMSO: 35 mg/mL(60.28 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方

2% DMSO+castor oil 10 mg/mL

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。